FindTrial
Sign In

Comparison of Inj. Dexmededitomedine with Inj. Bupivacaine versus Inj. Fentanyl with Inj. Bupivacaine for upper limb surgeries

To evaluate the effect of Dexmeditomedine And Fentanyl as an Adjuvant to Bupivacaine in USG Guided Supraclavicular Block for upper limb surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075413
Enrollment
60
Registered
2024-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomedine 50 mcg will be used as an intervention: In intervention group we will assess the effect of 50 micrograms Dexmedetomedine as adjuvant to Bupivacaine 0.5 % in supraclavicu

Sponsors

Datta Meghe Institute of Higher education and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status I & II Patients undergoing elective supraclavicular block for upper limb surgeries Patients aged between 18 and 60 years old Patient willing to participate in study

Exclusion criteria

Exclusion criteria: Patient refusal Allergy to Local anaesthetics and opioids Local infection at the site of block Pregnant women Severe cardiopulmonary disease Patients with neurological deficit in operating arm Bleeding disorders or patients on anticoagulants

Design outcomes

Primary

MeasureTime frame
the duration of analgesia between Inj. dexmeditomedine is prolonged when compared to Inj. fentanyl as an adjuvant to 0.5% bupivacaine for supraclavicular nerve blockTimepoint: 240 minutes—

Secondary

MeasureTime frame
Incidence of side effects was less in 50 mcg Dexmeditomedine when compared to Inj. Fentanyl group Timepoint: 240 minutes—

Countries

India

Contacts

Public ContactDr Karuna Taksande

Datta Meghe Institute of Higher Education and Research

karunahp1878@gmail.com7722037738

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026